GlassScriptPhysician profile
Paul L Burroughs
NPI 1588627582
$2,011.26
in general payments reported to CMS, 2019-2025
33 companies · $569 in 2025
The $569 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $93.19 · 2021: $312 · 2022: $147 · 2023: $369 · 2024: $194 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $313.80 | 2021-2025 | Persona |
| Ethicon US, LLC | $298.18 | 2019-2025 | Dermabond Prineo, Stratafix, Vistaseal |
| Vertex Pharmaceuticals Incorporated | $146.22 | 2024-2025 | |
| Si-Bone, INC. | $136.08 | 2020-2024 | |
| Abbott Laboratories | $129.93 | 2019-2024 | Proclaim, Lamitrode |
| Bioventus LLC | $107.46 | 2021-2025 | Gelsyn-3, Durolane, Durolane |
| Radius Health, INC. | $75.09 | 2021 | |
| Orthogenrx INC. | $71.33 | 2019-2021 | |
| Providence Medical Technology, INC. | $68.34 | 2025 | |
| Depuy Synthes Sales INC. | $64.30 | 2019-2023 | Orthovisc |
| Vericel Corporation | $49.58 | 2019 | |
| Smith+Nephew, INC. | $48.49 | 2025 | Real Intelligence |
| Abbvie INC. | $45.48 | 2022-2025 | |
| Biocomposites INC | $45.44 | 2025 | Stimulan |
| Fidia Pharma USA INC. | $37.62 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $32.36 | 2023 | |
| Moximed, INC | $28.26 | 2025 | Misha Knee System, Small, Left |
| Globus Medical, INC. | $27.94 | 2024 | Mini Fragment System, Clavicular Fracture Fixation, Ankle Fracture System |
| Kinex Medical Company LLC | $27.26 | 2019 | |
| Medtronic, INC. | $26.85 | 2021-2023 | Aquamantys(Tm) |
| Pacira Therapeutics, INC. | $25.53 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.52 | 2022 | |
| Amgen INC. | $22.42 | 2025 | Krystexxa |
| Stryker Corporation | $21.86 | 2025 | Triathlon |
| Pacira Pharmaceuticals Incorporated | $18.35 | 2023 | Iovera, Zilretta |
| Nevro Corp. | $17.90 | 2019 | |
| Davol INC. | $16.25 | 2023 | Arista Ah Flexitip |
| Orthofix Medical, INC. | $16.08 | 2020 | |
| Avanos Medical | $15.72 | 2023 | On-Q* Pump and Accessories |
| Heron Therapeutics, INC. | $15.21 | 2023 | Zynrelef |
| Ibsa Pharma INC. | $14.39 | 2020 | |
| Heraeus Medical, LLC. | $12.73 | 2023 | Palacos |
| Zyla Life Sciences, INC. | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Burroughs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.